Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment (original) (raw)

• Cole SL, Vassar R . The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. J Biol Chem 2008; 283: 29621–29625.
  Article CAS Google Scholar
• Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O et al. Amyloid deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol 2013; 12: 357–367.
  Article CAS Google Scholar
• Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L . Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5: 228–234.
  Article CAS Google Scholar
• Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597–610.
  Article CAS Google Scholar
• He L, Hannon GJ . MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522–531.
  Article CAS Google Scholar
• Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654–659.
  Article CAS Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513–10518.
  Article CAS Google Scholar
• Bellingham SA, Guo BB, Coleman BM, Hill AF . Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? Front Physiol 2012; 3: 124.
  Article CAS Google Scholar
• Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10: 1470–1476.
  Article CAS Google Scholar
• Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 2008; 3: e3694.
  Article Google Scholar
• Cheng L, Sharples RA, Scicluna BJ, Hill AF . Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 2014; 3. doi:10.3402/jev.v3.23743 (e-pub ahead of print)
• Cheng L, Quek CY, Sun X, Bellingham SA, Hill AF . The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies. Front Genet 2013; 4: 150.
  Article Google Scholar
• Coleman BM, Hanssen E, Lawson VA, Hill AF . Prion-infected cells regulate the release of exosomes with distinct ultrastructural features. FASEB J 2012; 26: 4160–4173.
  Article CAS Google Scholar
• Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 2010; 31: 1275–1283.
  Article Google Scholar
• Ellis KA, Rowe CC, Villemagne VL, Martins RN, Masters CL, Salvado O et al. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement 2010; 6: 291–296.
  Article Google Scholar
• Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 2009; 21: 672–687.
  Article Google Scholar
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944.
  Article CAS Google Scholar
• Cheng L, Sun X, Scicluna BJ, Coleman BM, Hill AF . Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. Kidney Int 2013; 86: 433–444.
  Article Google Scholar
• Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: 34.
  Article Google Scholar
• Kirschner MB, Edelman JJ, Kao SC, Vallely MP, van Zandwijk N, Reid G . The impact of hemolysis on cell-free microRNA biomarkers. Front Genet 2013; 4: 94.
  CAS PubMed PubMed Central Google Scholar
• Haqqani AS, Delaney CE, Tremblay TL, Sodja C, Sandhu JK, Stanimirovic DB . Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS 2013; 10: 4.
  Article CAS Google Scholar
• Huang X, Yuan T, Tschannen M, Sun Z, Jacob H, Du M et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics 2013; 14: 319.
  Article CAS Google Scholar
• Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O . Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 2009; 11: 1143–1149.
  Article CAS Google Scholar
• Mitchell JP, Court J, Mason MD, Tabi Z, Clayton A . Increased exosome production from tumour cell cultures using the Integra CELLine Culture System. J Immunol Methods 2008; 335: 98–105.
  Article CAS Google Scholar
• Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 2013; 14: R78.
  Article Google Scholar
• Kumar P, Dezso Z, MacKenzie C, Oestreicher J, Agoulnik S, Byrne M et al. Circulating miRNA biomarkers for Alzheimer's disease. PLoS ONE 2013; 8: e69807.
  Article CAS Google Scholar
• Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun 2013; 4: 2980.
  Article Google Scholar
• Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF . Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 2007; 211: 582–590.
  Article CAS Google Scholar
• Sharples RA, Vella LJ, Nisbet RM, Naylor R, Perez K, Barnham KJ et al. Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. FASEB J 2008; 22: 1469–1478.
  Article CAS Google Scholar
• Bellingham SA, Coleman BM, Hill AF . Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res 2012; 40: 10937–10949.
  Article CAS Google Scholar
• Long JM, Lahiri DK . MicroRNA-101 downregulates Alzheimer's amyloid-beta precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 2011; 404: 889–895.
  Article CAS Google Scholar
• Vilardo E, Barbato C, Ciotti M, Cogoni C, Ruberti F . MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem 2010; 285: 18344–18351.
  Article CAS Google Scholar
• Hebert SS, Papadopoulou AS, Smith P, Galas MC, Planel E, Silahtaroglu AN et al. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet 2010; 19: 3959–3969.
  Article CAS Google Scholar
• Finnerty JR, Wang WX, Hebert SS, Wilfred BR, Mao G, Nelson PT . The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol 2010; 402: 491–509.
  Article CAS Google Scholar
• Augustin R, Endres K, Reinhardt S, Kuhn PH, Lichtenthaler SF, Hansen J et al. Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med Genet 2012; 13: 35.
  Article CAS Google Scholar
• Kim J, Yoon H, Ramirez CM, Lee SM, Hoe HS, Fernandez-Hernando C . MiR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Exp Neurol 2012; 235: 476–483.
  Article CAS Google Scholar
• Wang H, Liu J, Zong Y, Xu Y, Deng W, Zhu H et al. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor. Brain Res 2010; 1357: 166–174.
  Article CAS Google Scholar
• Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT . Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 2011; 121: 193–205.
  Article Google Scholar
• Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimer's Dis 2008; 14: 27–41.
  Article CAS Google Scholar
• Rowe CC, Bourgeat P, Ellis KA, Brown B, Lim YY, Mulligan R et al. Predicting Alzheimer disease with beta-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. Ann Neurol 2013; 74: 905–913.
  Article CAS Google Scholar
• Blennow K, Hampel H, Weiner M, Zetterberg H . Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 2010; 6: 131–144.
  Article CAS Google Scholar
• Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B et al. Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol 2001; 58: 373–379.
  Article CAS Google Scholar
• Sala Frigerio C, Lau P, Salta E, Tournoy J, Bossers K, Vandenberghe R et al. Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease. Neurol 2013; 81: 2103–2106.
  Article CAS Google Scholar
• Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S et al. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimer's Dement 2011; 7: 386–395 e386.
  Article CAS Google Scholar
• Mapstone M, Cheema AK, Fiandaca MS, Zhong X, Mhyre TR, MacArthur LH et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 2014; 20: 415–418.
  Article CAS Google Scholar
• Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007; 13: 1359–1362.
  Article CAS Google Scholar
• Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA et al. Plasma amyloid-beta levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden. J Alzheimer's Dis 2014; 40: 95–104.
  Article CAS Google Scholar